B-cell reduction using CD37-specific and CD20-specific binding molecules
A Standard patent application filed on 25 July 2006 credited to Ledbetter, Jeffrey A. ; Grosmaire, Laura Sue ; Brady, William ; Thompson, Peter Armstrong ; Simon, Sandy Alexander ; Hayden-Ledbetter, Martha Susan

Details

Application number :

2006272555  

Application type :

Standard  

Application status :

SEALED  

Under opposition :

No  

Proceeding type :

 

Invention title :

B-cell reduction using CD37-specific and CD20-specific binding molecules  

Inventor :

Ledbetter, Jeffrey A. ; Grosmaire, Laura Sue ; Brady, William ; Thompson, Peter Armstrong ; Simon, Sandy Alexander ; Hayden-Ledbetter, Martha Susan  

Agent name :

Wrays  

Address for service :

Ground Floor 56 Ord Street West Perth WA 6005 Australia  

Filing date :

25 July 2006  

Associated companies :

 

Applicant name :

Emergent Product Development Seattle LLC  

Applicant address :

2401 Fourth Avenue Suite 1050 Seattle Washington 98121 United States of America  

Old name :

Trubion Pharmaceuticals, Inc.  

Original Source :

Go